Anne-Virginie Eggimann - 17 May 2021 Form 4 Insider Report for Codiak BioSciences, Inc.

Role
Director
Signature
/s/ Yalonda Howze by Power of Attorney for Anne-Virginie Eggimann
Issuer symbol
N/A
Transactions as of
17 May 2021
Net transactions value
$0
Form type
4
Filing time
21 May 2021, 17:22:13 UTC
Next filing
13 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 17 May 2021 Common Stock 20,000 $18.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in equal quarterly installments over 3 years.